HomeNewscoronavirusKeep LMO stock at 95% capacity, Maharashtra tells manufacturing units

Keep LMO stock at 95% capacity, Maharashtra tells manufacturing units

In an order issued during the day by Chief Secretary Sitaram Kunte, these units were asked to maintain 95 per cent stock by September 30, with district collectors being directed to ensure that LMO is stored to the maximum possible technically feasible level.

September 24, 2021 / 22:09 IST
Story continues below Advertisement
 (Representative image)
(Representative image)

After announcing the reopening of schools and places of worship from the first week of October as the number of coronavirus cases decline, the Maharashtra government on Friday asked liquid medical oxygen manufacturing units to maintain stock at 95 per cent capacity.

In an order issued during the day by Chief Secretary Sitaram Kunte, these units were asked to maintain 95 per cent stock by September 30, with district collectors being directed to ensure that LMO is stored to the maximum possible technically feasible level.

Story continues below Advertisement

ALSO READ: Religious places to reopen in Maharashtra from October 7: CM Uddhav Thackeray

The public health department, in consultation with the medical education and drugs departments, should adjust non-medical oxygen use as medical oxygen needs start rising, the order added. In case there is an increase in the number of infections post relaxation, there will be sufficient stock of LMO for patients with this order, an official said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show